Press Room

Find the latest news, high-quality multimedia, and expert contacts to ensure accurate and impactful storytelling. Our media team is here to assist you.

Media Contacts

Kelly Quigley
Director of Science Communications & Media Relations
kelly.quigley@gladstone.ucsf.edu

Julie Langelier
Associate Director of Communications
julie.langelier@gladstone.ucsf.edu

Connect with an Expert

Gladstone's investigators are at the forefront of biomedical research, covering a wide range of critical and emerging fields.

All Areas of Expertise

Alzheimer's and Other Dementias
Antibiotic Resistance
Artificial Intelligence for Drug Discovery
Autoimmune Diseases
Cancer
COVID-19 and Long COVID
CRISPR Genome Editing

Heart Disease
HIV/AIDS
Multiple Sclerosis
Stem Cells and Regenerative Medicine
Traumatic Brain Injury
Vaccines
Viruses and Infectious Diseases

Submit a Media Request

Our Experts

Gladstone President, Deepak Srivastava, MD

Deepak Srivastava, MD

Deepak Srivastava is president of Gladstone Institutes. He is also the Younger Family Professor and a senior investigator at the Gladstone Institute of Cardiovascular Disease, and director of the Roddenberry Stem Cell Center.

Talk to Deepak about:

Stem cells for curative therapies
Artificial intelligence for drug discovery and development
Latest discoveries for heart health

Request an Interview

Benoit Bruneau, PhD

Director, Gladstone Institute of Cardiovascular Disease

Steve Finkbeiner, MD, PhD

Director, Center for Systems and Therapeutics

Alex Marson, MD, PhD

Director, Gladstone-UCSF Institute of Genomic Immunology

Lennart Mucke, MD

Director, Gladstone Institute of Neurological Disease

Melanie Ott, MD, PhD

Director, Gladstone Infectious Disease Institute

Katie Pollard, PhD

Director, Gladstone Institute of Data Science and Biotechnology

Gladstone in the News

Facts and Figures

32

Research Labs

45

Years of disease-driven research

600+

Scientists

5

Institutes

Gladstone Institutes is an independent, nonprofit research organization driving a new era in biomedical innovation—an era in which it’s possible to contemplate cures, not just treatments. Read more about what sets Gladstone apart.

Meet Our Leadership